The pharmaceutical industry is rapidly evolving, with increasing demand for high-efficacy Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, is a key example of this trend. To fulfill https://tirzepatides.us/peptides